The lung metastasis test showed that the degree of tumor metastasis and the average area of IFITM3 immune-positive lung tissue were significantly reduced after knocking down TUG1, whereas simultaneous knocking down TUG1 and miR-29a resulted in findings similar to those obtained in the control group (Figure 9E, 9F). The gene discussed is TUG1; the disease is neoplasm.